COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Last week, the Food and Drug Administration (FDA) granted emergency use authorization for the first breathalyzer test designed to detect COVID-19 in adults.
Adults who received an initial Johnson & Johnson (J&J) COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection
Federal officials at the Centers for Medicare and Medicaid Services and the Centers for Disease Control and Prevention called for a renewed focus on patient safety
Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants
To improve care delivery, conserve personal protective equipment and limit the exposure to SARS-CoV-2, nurses at Montefiore Medical Center in New York City relocated smart IV infusion pumps outside of patient rooms
The Food and Drug Administration (FDA) warned people to stop using two tests produced by Empowered Diagnostics: CovClear COVID-19 Rapid Antigen Test
On Jan. 13, the Supreme Court of the United States (SCOTUS) issued its ruling on a challenge to the Centers for Medicare and Medicaid Services (CMS) requirement that health care facilities accepting CMS payment vaccinate their employees against COVID-19.
The American Hospital Association (AHA) this week urged the Centers for Medicare & Medicaid Services (CMS) to be flexible as it begins enforcing its COVID-19 vaccine mandate for hospitals
Changes to guidance from the Centers for Disease Control and Prevention (CDC) have left nurses who test positive for COVID-19 questioning how best to protect their patients.
A new page on the Food and Drug Administration (FDA) website explains how genetic mutations in the COIVID-19 virus may impact the accuracy of existing tests for SARS-CoV-2.